Mazor Robotics Ltd  

(Public, OTCMKTS:MZRTF)   Watch this stock  
Find more results for PINK:MZRTF
0.00 (0.00%)
Feb 9 - Close
OTCMKTS data delayed by 15 mins - Disclaimer
Currency in USD
Range     -
52 week 4.25 - 7.35
Open     -
Vol / Avg. 0.00/755.00
Mkt cap 745.07M
P/E     -
Div/yield     -
EPS -1.23
Shares 42.35M
Beta 1.81
Inst. own     -
May 4, 2016
Q1 2016 Mazor Robotics Ltd Earnings Release (Estimated) Add to calendar
Feb 18, 2016
Q4 2015 Mazor Robotics Ltd Earnings Release - 9:30AM EST - Add to calendar
Feb 18, 2016
Q4 2015 Mazor Robotics Ltd Earnings Call - 8:30AM EST - Add to calendar
Feb 9, 2016
Mazor Robotics Ltd Annual Shareholders Meeting (Estimated)
Jan 14, 2016
Mazor Robotics Ltd at Needham Growth Conference

Key stats and ratios

Q3 (Sep '14) 2013
Net profit margin -63.59% -102.73%
Operating margin -57.51% -34.67%
EBITD margin - -31.62%
Return on average assets -23.75% -44.52%
Return on average equity -26.59% -53.38%
Employees 141 -
CDP Score - -


7 HaEshel St. Caesarea Industrial Park South PO Box 3104
+972-4-6187100 (Phone)
+972-4-6187111 (Fax)

Website links


Mazor Robotics Ltd is an Israel-based medical device company that develops and markets surgical guidance systems and complementary products. It develops computerized and imaging-based systems in the field of spine surgery. Its products include: Renaissance Surgical Guidance System, which enables surgeons to advance from freehand surgical procedures to guided procedures, as well as Food and Drug Administration (FDA)-cleared and European Conformity (CE)-marked Renaissance System, used in spine surgeries, whether open or minimally invasive, for a number of clinical indications. Its Renaissance System and its predecessor are used in a number of spine surgeries, including fusion, correction of spinal deformities, biopsy collection, tumor excision and cement augmentations. Furthermore the Company developed the Renaissance Brain Module, an application of its Renaissance System that provides control over the insertion of surgical instruments during brain surgery.

Officers and directors

Jonathan Adereth Chairman of the Board
Age: 66
Ori Hadomi Chief Executive Officer, Director
Age: 47
Sharon Levita Chief Financial Officer, Secretary
Age: 45
Eliyahu Zahavi Chief Operating Officer
Age: 58
Moshe Shoham Chief Technology Officer
Age: 63
Sandra Adzic Vice President of International Sales
Anat Kaphan Vice President of Marketing and Product Management
Doron Dinstein Chief Medical Officer
Age: 42
Michael Berman Director
Age: 57
Sarit Sukari Soccary Ben-Yochanan Director
Age: 41